Search Results (120)
Documents on Securities, Health Care, Biotech & Life Sciences
Show: results per page
|Major SEC Rule Changes Will Impact Equity Fundraising|
Aaron D. Zibart; Wyatt, Tarrant & Combs, LLP;
October 1, 2013, previously published on September 20, 2013Effective September 23, a new SEC rule (506(c)) will allow advertising and general solicitation in certain unregistered securities offerings. The basic requirements of the new rule are:
|The Fifth Circuit Affirms the Derivative Nature of Dilution Claims and Lack of Minority Shareholder Oppression under Delaware Law|
Nicholas Even, Matt McGee; Haynes and Boone, LLP;
August 16, 2013, previously published on August 14, 2013On August 12, 2013, the United States Court of Appeals for the Fifth Circuit in Joe W. and Dorothy Dorsett Brown Foundation, et. al. v. Frazier Healthcare V, L.P., et al. affirmed the decision of the United States District Court for the Western District of Texas dismissing with prejudice all claims...
|Ontario Court Rejects Dissident Shareholders’ Attempt to Call Shareholder Meeting|
Michael Partridge; Goodmans LLP - Toronto;
July 26, 2013, previously published on July 25, 2013The Ontario Superior Court of Justice’s recent decision in Wells v. Bioniche Life Sciences Inc. provides important guidance on a number of matters relating to a dissident shareholder’s ability to requisition and call a shareholder meeting under the Canada Business Corporations Act...
|Mutual Funds’ After-Tax Returns Adjusted for Tax on Net Investment Income|
Michael G. Dana, Peter D. Fetzer, Terry D. Nelson; Foley & Lardner LLP;
April 2, 2013, previously published on March 28, 2013The SEC staff has announced that reported after-tax returns for mutual funds and exchange-traded funds must be adjusted to reflect the 3.8% tax on net investment income that became applicable to some taxpayers on January 1, 2013. This affects fund advertising as well as required disclosures in the...
|Convergence and Divergence on Securities Class Actions|
Brandon Barnes, Kate Southwell; Davis LLP;
March 14, 2013, previously published on March 14, 2013The class action is a litigation technique that lends itself well to claims by security-holders against issuers. The classes of purchasers of securities are easily definable, the losses are often all too publicly ascertainable, and the procedural benefits of one large claim (as opposed to a...
|Data Privacy Day 2013 - Tip #2 - Dust Off Your Information Security Policy (or Start Putting One in Place...)|
Amy Malone; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.;
January 30, 2013, previously published on January 28, 2013Do you have a comprehensive information security program? Many businesses are still operating without one, leaving them open to preventable data breaches. The importance of info security programs was yet again underscored by the recent settlement between Cbr Systems and the Federal Trade...
|This Week at the SCC|
Brandon Kain, Brandon Kain; McCarthy Tétrault LLP;
December 6, 2012, previously published on December 2, 2012The Supreme Court of Canada released one decision this week of interest to Canadian businesses and professions.
|DOJ and SEC Issue Highly Anticipated FCPA Guidance|
Karen S. Lovitch, Paul E. Pelletier, Aaron M. Tidman; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.;
November 21, 2012, previously published on November 15, 2012On November 14th, the U.S. Department of Justice (“DOJ”) and the U.S. Securities and Exchange Commission (“SEC”) published A Resource Guide to the U.S. Foreign Corrupt Practices Act, their long-awaited, highly anticipated guidance on the FCPA. The guidance is not...
|The Calm Before the Storm: New Jersey Magistrate Judge Declines Selective Waiver Approach|
Thomas C. Regan; LeClairRyan;
October 15, 2012, previously published on October 10, 2012In a letter opinion issued October 5, 2012, Magistrate Judge Cathy Waldor ordered Merck & Co., Inc. to turn over documents claimed to be privileged because those same documents had earlier been voluntarily delivered to the federal government.
|Recent Bankruptcy Reminds Companies of Need for Use of Registered Broker-Dealers in Capital Raising Efforts|
Margaret R. Blake, Amy Natterson Kroll, Carl A. Valenstein; Bingham McCutchen LLP;
September 18, 2012, previously published on September 12, 2012In July 2012, Neogenix Oncology Inc., (“Neogenix” or “Company”) a biotech firm based in Rockville, Maryland and New York, surprised investors by filing for Chapter 11 bankruptcy protection. To those in the biotech industry, Neogenix, by all accounts, was a successful company...